The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial
Social Determinants of Health · 2024 · 10 (1)
DOI: 10.22037/sdh.v10i1.43032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Social Determinants of Health, 2024. Verfasst von Arezoo Chouhdari.
Abstract (Originalsprache)
Background
Laboratory and observational data suggest that hydroxychloroquine (HCQ) has biological activity against SARS-CoV-2, potentially permitting its use for disease prevention. This study aimed to evaluate the hydroxychloroquine effect as prophylaxis for SARS-CoV-2 infection.
Methods
This double-blind randomized controlled trial was performed on 1000 people between 18-65 who were not suspected of having COVID-19 symptoms at the time of enrollment and had no positive COVID-19 virus test. Hydroxychloroquine or placebo tablets (800 mg/d for the first day followed by 200 mg/d for 6 weeks) were prescribed randomly for participants in 2 groups and followed for 10 weeks.
Results
Among 871 participants who were followed within 10 weeks 97(11.1%) became SARS-CoV-2 positive. there were statistically significant differences between infected or non-infected in the hydroxychloroquine (36 of 97 [37.1%]) and placebo (61 of 97 [62.9 %]) groups with a risk ratio of 2.1 (95% confidence interval (CI) 1.01 - 3.21; p = 0.005). The incidence of severe forms of COVID-19 (i.e., hospitalized in the coronavirus ward or the ICU) was 2 of 97 (0.02 %) in participants who received a placebo compared to hydroxychloroquine. The proportion of non-infected people who received hydroxychloroquine prophylaxis was nearly twice higher than that of placebo users (1.87, 95% CI: 1.19 - 2.84, p = 0.05). There were no significant differences between the two groups regarding side effects (1.1% vs. 0.9%), and no severe adverse reactions were observed.
Conclusion
Pre-exposure therapy with hydroxychloroquine appears to prevent moderate and severe illness caused by COVID-19 in asymptomatic persons.
Schlagwörter
Zitieren
APA
Chouhdari, A. (2024). The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial. Social Determinants of Health, 10(1). https://doi.org/10.22037/sdh.v10i1.43032
Vancouver
Chouhdari A. The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial. Social Determinants of Health. 2024;10(1). doi:10.22037/sdh.v10i1.43032
BibTeX
@article{Chouhdari2024,
author = {Chouhdari, Arezoo},
title = {The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial},
journal = {Social Determinants of Health},
year = {2024},
volume = {10},
number = {1},
doi = {10.22037/sdh.v10i1.43032}
}
EUVIMED